OTHER INFORMATION
+Added: Rule 10b5-1 Trading Plans
+Added: Ramiro Peru, a member of our Board of Directors, adopted a stock trading plan on May 3, 2023, pursuant to which he may sell up to 753 shares of the Company’s common stock prior to April 22, 2024.
+Added: This trading plan was entered into during an open insider trading window and is intended to satisfy the affirmative defense of Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended, and the Company’s policies regarding transactions in our securities.
3.1 Amended and Restated Articles of Incorporation of the Company, as amended and restated effective June 27, 2022, incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed on June 28, 2022.
2 unchanged sentences
Securities and Exchange Commission, the Company will furnish copies of any other instruments defining the rights of holders of long-term debt of the Company or its subsidiaries.
−Removed: 10.2 * (o) Form of Incentive Compensation Plan Non Qualified Stock Option Award Agreement for 2023.
−Removed: * (p) Form of Incentive Compensation Plan Restricted Stock Unit Award Agreement for 2023.
−Removed: * (q) Form of Incentive Compensation Plan Performance Stock Unit Award Agreement for 2023.
+Added: 10.7 Elevance Health Board of Directors Compensation Program, as amended and restated effective May 10, 2023.
31.1 Certification of Chief Executive Officer pursuant to Rule 13a-14(a) and Rule 15d-14(a) of the Exchange Act Rules, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
4 unchanged sentences
Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
−Removed: 101 The following material from Elevance Health, Inc.’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2023, formatted in Inline XBRL (Inline Extensible Business Reporting Language):
+Added: 101 The following material from Elevance Health, Inc.’s Quarterly Report on Form 10-Q for the quarter ended June 30, 2023, formatted in Inline XBRL (Inline Extensible Business Reporting Language):
(i) the Consolidated Balance Sheets;
9 unchanged sentences
ELEVANCE HEALTH, INC.
−Removed: April 19, 2023 By:
+Added: July 19, 2023 By:
/ S / J OHN E.
1 unchanged sentence
(Duly Authorized Officer and Principal Financial Officer)
−Removed: April 19, 2023 By:
+Added: July 19, 2023 By:
/ S / R ONALD W.
2 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.